Matthew Ganovsky - 13 Feb 2026 Form 4 Insider Report for Abacus Global Management, Inc. (ABX)

Reporting relationship: Co-Founder and President, 10%+ Owner
Issuer ticker: ABX
Reported as of: 13 Feb 2026
Net transaction value: +$47,198
SEC form: 4
Accepted by SEC: 18 Feb 2026, 19:58:32 UTC
Prior SEC filing: 11 Aug 2025
Next SEC filing: 16 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jay Jackson, Power of Attorney for Matthew Ganovsky

Key filing fact

Matthew Ganovsky filed Form 4 for Abacus Global Management, Inc. (ABX) on 18 Feb 2026.

Key facts

This page summarizes Matthew Ganovsky's Form 4 filing for Abacus Global Management, Inc. (ABX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 18 Feb 2026, 19:58.

Change

Previous filing in this sequence was filed on 11 Aug 2025.
Current net transaction value: +$47,198.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982989 Primary reporting owner

Ganovsky Matthew

Relationship: Co-Founder and President, 10%+ Owner
Address: 2101 PARK CENTER DRIVE, SUITE 200, ORLANDO
Signature: /s/ Jay Jackson, Power of Attorney for Matthew Ganovsky
Signature date: 18 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABX transaction

Common Stock

Award

Transaction value: $67,200
Shares: +8,000
Change %: +0.09%
Price: $8.40
Shares after: 8,612,010
Date: 13 Feb 2026
Ownership: Direct
Footnotes: F1, F2, F3

ABX transaction

Common Stock

Sale

Transaction value: $20,002
Shares: -2,386
Change %: -0.03%
Price: $8.38
Shares after: 8,609,624
Date: 18 Feb 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Includes 8,000 shares of Common Stock that vested on February 13, 2026 (in connection with the Issuer's grant of 24,000 Restricted Stock Units (RSUs) to the Reporting Person on February 13, 2024 with a third of the total amount granted on each of the first three anniversaries of the grant date).

Footnote F2

Includes certain time-based RSUs that remain outstanding that will vest and be converted to a like number of the Issuer's Common Stock that were previously reported on Table II, including 81,856 time-based RSUs, granted on April 3, 2025, a third of which will vest on each of March 27, 2026, March 27, 2027 and March 27, 2028, and including RSUs granted to the Reporting Person on February 13, 2024, a third of which vest on each anniversary of the grant, with 8,000 remaining and scheduled to vest on February 13, 2027.

Footnote F3

Does not include 3,847,046 shares of Common Stock held by trusts established by the Reporting Person, of which the Reporting Person disclaims beneficial ownership.

Footnote F4

Includes the sale reported on this Form 4, which represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person has elected to satisfy tax withholding obligations through a "sell to cover" transaction.